Torrent Pharmaceuticals has registered 80.09% jump in net profit at Rs 80.07 crore for the quarter ended March 31, 2012, compared with a profit of Rs 44.46 crore for the same quarter a year ago.
The company’s total income surged 34.13% to Rs 544.59 crore for the quarter under review as compared to Rs 406.03 crore for the corresponding quarter previous fiscal.
The PSU firm’s net profit for the full financial year 2011-12 rose 7.01% to Rs 311.25 crore in the year under review as against Rs 290.86 crore in FY11. However, total income increased by 18.51% to Rs 2076.04 crore for the year ended March 31, 2012 from Rs 1751.73 crore in FY11.
Torrent Pharmaceuticals has recommended a final dividend of Rs 2.50 per equity share of Rs 5 each fully paid up.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: